Please use this identifier to cite or link to this item:
|Title:||A Proposed Eye Irritation Testing Strategy to Reduce and Replace In Vivo Studies Using Bottom-Up and Top-Down Approaches|
|Authors:||SCOTT Laurie; ESKES Chantra; HOFFMAN Sebastian; ADRIAENS Els; ALEPEE Nathalie; BUFO Monica; CLOTHIER Richard; FACCHINI Davide; FALLER Claudine; GUEST Robert; HARBELL John; HARTUNG Thomas; KAMP Hennicke; LE VARLET Beatrice; MELONI Marisa; MCNAMEE Pauline; OSBORNE Rosemarie; PAPE Wolfgang; PFANNEBECKER Uwe; PRINSEN Menk; SEAMAN Christopher; SPIELMANN Horst; STOKES William; TROUBA Kevin; VAN DEN BERGHE Christine; VAN GOETHEM Freddy; VASSALLO Marco; VINARDELL Pinar; ZUANG Valerie|
|Citation:||TOXICOLOGY IN VITRO vol. 24 no. 1 p. 1-9|
|Publisher:||PERGAMON-ELSEVIER SCIENCE LTD|
|Type:||Articles in Journals|
|Abstract:||In spite of over 20 years of effort, no single in vitro assay has been developed and validated as a full regulatory replacement for the Draize Eye Irritation test. However, companies have been using in vitro methods to screen new formulations and in some cases as their primary assessment of eye irritation potential for many years. The present report shows the outcome of an Expert Meeting convened by the European Centre for the Validation of Alternative Methods in February 2005 to identify test strategies for eye irritation. In this workshop test developers/users were requested to nominate methods to be considered as a basis for the identification of such testing strategies. Assays were evaluated and categorized based on their proposed applicability domains (e.g., categories of irritation severity, modes of action, chemical class, physicochemical compatibility). The analyses were based on the data developed from current practice and published studies, the ability to predict depth of injury (within the applicable range of severity), modes of action that could be addressed and compatibility with different physiochemical forms. The difficulty in predicting the middle category of irritancy (e.g. R36, GHS Categories 2A and 2B) was recognized. The testing scheme proposes using a Bottom-Up (begin with using test methods that can accurately identify non-irritants) or Top-Down (begin with using test methods that can accurately identify severe irritants) progression of in vitro tests (based on expected irritancy). Irrespective of the starting point, the approach would identify non-irritants and severe irritants, leaving all others to the (mild/moderate) irritant GHS 2 / R36 categories.|
|JRC Institute:||Institute for Health and Consumer Protection|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.